Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 28, 2011; 17(36): 4076-4089
Published online Sep 28, 2011. doi: 10.3748/wjg.v17.i36.4076
Published online Sep 28, 2011. doi: 10.3748/wjg.v17.i36.4076
Figure 9 The area of colonic lesions and plasma levels of proinflammatory cytokines IL-1β and tumor necrosis factor-α on day 10 after induction of colitis in rats treated with aspirin or celecoxib with or without 16, 16 dm prostaglandin E2 (5 μg/kg per day ig).
Mean ± SE of 6-8 rats. aP < 0.02 vs vehicle (control); cP <0.02 vs vehicle-treated and aspirin (ASA)-treated groups; eP < 0.02 vs ASA and celecoxib groups without concurrent prostaglandin E2 (PGE2) administration. TNBS: Trinitrobenzenesulfonic acid; TNF: Tumor necrosis factor.
- Citation: Zwolinska-Wcislo M, Brzozowski T, Ptak-Belowska A, Targosz A, Urbanczyk K, Kwiecien S, Sliwowski Z. Nitric oxide-releasing aspirin but not conventional aspirin improves healing of experimental colitis. World J Gastroenterol 2011; 17(36): 4076-4089
- URL: https://www.wjgnet.com/1007-9327/full/v17/i36/4076.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i36.4076